Governing AI for Pharmacovigilance in Low-Income Countries: Systems Perspective
Abstract Gaps in pharmaceutical governance could widen with the adoption of AI, even as AI promises better pharmacovigilance in low-income countries (LICs). While advanced regulatory systems like Australia’s are integrating AI into pharmaceutical governance, LICs with underdeveloped regulatory capabilities, such as Sou...